Medicare Will Cover Prostate Cancer Drug

Medicare announced Thursday it will cover Dendreon’s prostate cancer drug Provenge, which has been shown to extend life for about four months for patients with late stages of the disease but costs up to $93,000.

Read more from the

blog comments powered by Disqus
Thursday Night Football

Listen Live